Description
Book SynopsisThe 12th volume of International Development Policy explores the relationship between international drug policy and development goals, both current and within a historical perspective. Contributions address the drugs and development nexus from a range of critical viewpoints, highlighting gaps and contradictions, as well as exploring strategies and opportunities for enhanced linkages between drug control and development programming. Criminalisation and coercive law enforcement-based responses in international and national level drug control are shown to undermine peace, security and development objectives. Contributors include: Kenza Afsahi, Damon Barrett, David Bewley-Taylor, Daniel Brombacher, Julia Buxton, Mary Chinery-Hesse, John Collins, Joanne Csete, Sarah David, Ann Fordham, Corina Giacomello, Martin Jelsma, Sylvia Kay, Diederik Lohman, David Mansfield, José Ramos-Horta, Tuesday Reitano, Andrew Scheibe, Shaun Shelly, Khalid Tinasti, and Anna Versfeld.
Trade Review"In the era of sustainable development, cross-cutting issues such as drug control—with real-life impacts on public health, public security and the enjoyment of human rights—need to be aligned with the priorities of achieving the 2030 Agenda. This volume by International Development Policy and the Global Commission on Drug Policy provides an insight into the political, economic and social barriers to needed drug policy reforms." — Helen Clark, former Administrator of UNDP; member of the Global Commission on Drug Policy "With a complex architecture, multi-stakeholder involvement, and multi-sector intervention, drug policy remains a neglected area in public policy analysis, while it engages massive resources and directly impacts development indicators. This volume of International Development Policy provides the reader with a structured path via which to capture the challenges that drug policy poses, and how they translate as barriers to development on the ground." — Mohammad-Mahmoud Ould Mohamedou, Professor of International History, the Graduate Institute
Table of ContentsForeword Preface List of Illustrations List of Acronyms and Abbreviations Notes on Contributors Introduction 1 Are Barriers to Sustainable Development Endogenous to Drug Control Policies? Khalid Tinasti, Julia Buxton and Mary Chinery-Hesse PART 1 Milestones of Drug Policies and Development 2 Drug Control and Development: a Blind Spot Julia Buxton 3 Imperial Drug Economies, Development, and the Search for Alternatives in Asia, from Colonialism to Decolonisation John Collins 4 From Alternative Development to Development-oriented Drug Policies Daniel Brombacher and Sarah David 5 Trying to Be All Things to All People: Alternative Development in Afghanistan David Mansfield 6 Cannabis Regulation and Development: Fair(er) Trade Options for Emerging Legal Markets David Bewley-Taylor, Martin Jelsma and Sylvia Kay PART 2 Human Development and Drug Policies 7 Making War: Conflict Zones and Their Implications for Drug Policy Tuesday Reitano 8 The Neo-patrimonial ‘Use’ of Drug Policy in Electoral Processes Khalid Tinasti 9 The Meaningful Participation of ‘Stakeholders’ in Global Drug Policy Debates—A Policy Comment Ann Fordham 10 The World Drug Policy Problem: Interview with José Ramos-Horta José Ramos-Horta and Khalid Tinasti PART 3 Drugs, Development and Cross-cutting Issues 11 The Rif and California: Environmental Violence in the Era of New Cannabis Markets Kenza Afsahi 12 The Gendered Impacts of Drug Policy on Women: Case Studies from Mexico Corina Giacomello 13 Incorporating Child Rights into Scheduling Decisions at the UN Commission on Narcotic Drugs Damon Barrett and Diederik Lohman 14 More Harm than Public Health in Drug Policy? A Comment Joanne Csete 15 Prohibitionist Drug Policy in South Africa—Reasons and Effects Andrew Scheibe, Shaun Shelly and Anna Versfeld Index
